Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: A report of 16 cases and review of the literature
Authors:
- Lauren BrunierLBLauren Brunier
- Jean SibiliaJSJean Sibilia
- François MaurierFMFrançois Maurier
- Marc ArdizzoneMAMarc Ardizzone
- Daniel WendlingDWDaniel Wendling
- Ghislaine GillGGGhislaine Gill
- Elisabeth PalazzoEPElisabeth Palazzo
- Olivier MeyerOMOlivier Meyer
- Philippe DieudéPDPhilippe Dieudé
- 1 March 2013
- journal article
- case report
- Published by Elsevier in Joint Bone Spine
- Vol. 80 (2) , 178-182
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Inflammasome Activators Induce Interleukin-1α Secretion via Distinct Pathways with Differential Requirement for the Protease Function of Caspase-1Immunity, 2012
- European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosisAnnals of the Rheumatic Diseases, 2011
- Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injuryWorld Journal of Gastroenterology, 2011
- Anti-IL-1 molecules: New comers and new indicationsJoint Bone Spine, 2010
- Colchicine Update: 2008Seminars in Arthritis and Rheumatism, 2009
- An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition diseaseRheumatology, 2009
- Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound studyOsteoarthritis and Cartilage, 2009
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2006
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Anti-inflammatory agents and renal function☆, ☆☆Seminars in Arthritis and Rheumatism, 2002